Posts Tagged ‘Technology Stocks’

DYSL barrels out of blocks, C hires, XOMA trails off

Wednesday, March 23rd, 2011

Dynasil Corporation (Nasdaq: DYSL) shares skyrocketed 70.2% to $6.62, on volume of 156,500 shares, towering over its average of 9,172 a day, after it announced that its research division was granted additional U.S. patent claims for advances in a detector material capable of responding independently to both neutron and gamma radiation.

Citigroup Inc. (NYSE: C) was a volume leader in early trading on Wednesday, dealing in 114.7 million shares, against a full-day average of 487.6 million. Share prices eased 1.6% to $4.35, after C announced the hiring of former StanChart banker Martin Lovegrove to head its energy services division.

Xoma Ltd. (Nasdaq: XOMA) shares were off 28.5% to $3.59, on volume of 2.6 million, catching up on a daily average of 4.2 million, a day after the company said a diabetes-treatment candidate did not yield better results than a placebo in a study.

FORM firm, SIRI flat, CELL is selling

Monday, March 21st, 2011

FormFactor Inc.(Nasdaq: FORM) shares climbed 14.6% Monday to $9.90, on volume of just over a million shares, nearly twice what it would normally trade in a day, after a Citigroup analyst noted that the provider of test equipment to the semiconductor industry had a large order.

Sirius XM Radio Inc. (Nasdaq: SIRI) traded in 30 million shares Monday, and while impressive, it was just barely half of its normal volume of 56 million. Share prices were flat at $1.71, on word that meal ticket Howard Stern announced he was cutting back on his workload.

Brightpoint Inc. (Nasdaq: CELL) fell 15.3% Monday to $10.70, on volume of 2.8 million shares, or four times its normal volume, after the company entered into a strategic alliance with Intcomex.

CMT balloons, INTC in disarray, CCI falls off throne

Monday, March 21st, 2011

Core Molding Technologies Inc. (AMEX: CMT) shares gained 19.7% to $7.30, on 96,756 shares, dwarfing its all-day average of 7,634 after the maker of truck accessories reported higher sales in its fourth quarter.

Intel Corporation (Nasdaq: INTC) traded in 36.6 million shares, making headway against an all-day average of 57.3 million shares, after the resignation of its senior vice president Anand Chandrasekher

Crown Castle International Corp. (NYSE: CCI) shares shed 4.7% to $37.32, on volume of 12.2 million shares, or six times its daily average, after Raymond James & Associates downgraded the operator of wireless infrastructure to outperform from strong buy.

MSHL moves, MSFT busy, MAJC miserable

Monday, March 21st, 2011

Marshall Edwards, Inc.(Nasdaq : MSHL) shares boosted 13.3% to $1.70, on volume of 45,250 shares, shy of its all-day average of 57,758, after it announced today the publication of results from a Phase II clinical trial of intravenous Phenoxodiol in combination with cisplatin in women with platinum-resistant ovarian cancer.

Microsoft Corporation (Nasdaq: MSFT) dealt in 26.2 million shares, making it one of the leaders, but still short of its average of 58.7 million. Shares for the computer behemoth advanced 2.1% to $25.33, amid strength in the tech industry.

Majestic Capital Inc. (Nasdaq: MAJC) lost its parachute and dropped 72.7% in price Monday to $1.18, on volume of 1.3 million shares, towering over a daily average of around 5,300, as the company mulls bankruptcy following a termination of a merger agreement with Bayside Capital Partners.

TGE shouts, CSCO sells widely, XNPT dips

Monday, March 21st, 2011

TGC Industries Inc. (Nasdaq: TGE) shares soared 14.5% to $7.82, on volume of 603,000 shares, or eight times its daily volume, after Dawson Geophysical Co. (Nasdaq: DWSN) said it would acquire the provider of seismic data to oil and gas producers for about $157 million in stock. DWSN shares advanced 1.1% to $43.00.

Cisco Systems (Nasdaq: CSCO) dealt in 24.7 million shares, catching up rapidly on a daily average of 71.2 million. Share prices gained 1.9% to $17.47.

XenoPort Inc.(Nasdaq: XNPT) shares fell 10.3% to $5.98, on volume of 4.4 million, or nine times its daily volume, after the company said it would halt development of its experimental heartburn treatment.